Covid-19 vaccine immunogenicity in people living with HIV-1
L. Nault, L. Marchitto, G. Goyette, D. Tremblay-Sher, C. Fortin, V. Martel-Laferriere, B. Trottier, J. Richard, M. Durand, D. E. Kaufmann, A. Finzi, C. Tremblay
This study evaluates mRNA vaccine immunogenicity in HIV-positive individuals, finding similar anti-RBD IgG responses to controls in those with CD4 counts >250 cells/mm3, but significantly lower responses in those with <250 cells/mm3.
bioRxiv · Aug 13, 2021Immunology